(Q44628811)

4 December 2017

Treatment of alcohol abuse: an evidence-based review (English)

1 reference

4 December 2017

Treatment of Alcohol Abuse: An Evidence‐Based Review (English)

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

24 March 2024

1 reference

3

Mikko Salaspuro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574236

24 March 2024

4

Johan Franck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14574236

24 March 2024

author name string

Mats Berglund

1

1 reference

4 December 2017

Sten Thelander

2

1 reference

4 December 2017

Sven Andréasson

5

1 reference

4 December 2017

Agneta Ojehagen

6

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14574236

24 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1097%2F01.ALC.0000090144.99832.19

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

https://onlinelibrary.wiley.com/doi/pdf/10.1097/01.ALC.0000090144.99832.19

24 March 2024

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Alcoholism: Clinical and Experimental Research

24 March 2024

published in

1 reference

4 December 2017

27

1 reference

4 December 2017

10

1 reference

4 December 2017

1645-1656

1 reference

Alcohol counseling: physicians will do it

4 December 2017

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

An evaluation of three treatment programmes for alcoholism: an experimental study with 6- and 8-month follow-ups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Successful use of propofol in refractory delirium tremens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Alcoholism treatment and medical care costs from Project MATCH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Maritally distressed women with alcohol problems: the impact of a short-term alcohol-focused intervention on drinking behaviour and marital satisfaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Secondary prevention with college drinkers: evaluation of an alcohol skills training program

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Prevention of alcohol-related deaths in middle-aged heavy drinkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Enhancing motivation for change in problem drinking: a controlled comparison of two therapist styles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Paroxetine for social anxiety and alcohol use in dual-diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Alcohol Interventions in a Trauma Center as a Means of Reducing the Risk of Injury Recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000090144.99832.19

Behavioral self-management controlled-drinking strategies in a context of secondary prevention

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Alcoholism and depression: a placebo controlled study with viloxazine

24 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

The 'pressures to change' approach to working with the partners of heavy drinkers.

24 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A comparison of home detoxification and minimal intervention strategies for problem drinkers

24 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

3 methods of treating delirium tremens. Comparative study

24 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study

24 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Buspirone in the treatment of alcoholic patients.

24 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Evaluation of treatment with hemineurine in delirium tremens

24 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse

24 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Advice versus extended treatment for alcoholism: a controlled study

24 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse

24 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial

24 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure

24 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Alcoholism: a controlled trial of "treatment" and "advice"

24 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Outcome studies of brief alcohol intervention in general practice: the problem of lost subjects

24 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Attempted referral as intervention for problem drinking in the general hospital

24 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

24 March 2024

Delirium tremens

30

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices.

24 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Treatment of the acute alcohol withdrawal state: a comparison of four drugs

24 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Buspirone Treatment of Anxious Alcoholics

24 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Naltrexone in the treatment of alcohol dependence

24 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Propofol in delirium tremens.

24 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A placebo-controlled trial of buspirone in anxious inpatient alcoholics

24 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

24 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal

24 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial

24 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Deficiencies of Clinical Trials of Alcohol Withdrawal

24 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Nonpharmacologic intervention in acute alcohol withdrawal

24 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Imipramine treatment of alcoholism with comorbid depression

24 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: does it work?

24 March 2024

71

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

24 March 2024

72

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study

24 March 2024

75

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders

24 March 2024

77

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes

24 March 2024

78

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH Three-Year Drinking Outcomes

24 March 2024

79

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Placebo-controlled study of sertraline in depressed recently abstinent alcoholics

24 March 2024

81

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Treatment settings for persons with alcoholism: evidence for matching clients to inpatient versus outpatient care

24 March 2024

83

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence

24 March 2024

85

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Randomized controlled trial of general practitioner intervention in women with excessive alcohol consumption

24 March 2024

87

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Diazepam loading: simplified treatment of alcohol withdrawal.

24 March 2024

89

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence

24 March 2024

90

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Brief intervention in a primary care setting for hazardous drinkers.

24 March 2024

91

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study

24 March 2024

95

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Naltrexone in the treatment of alcohol dependence

24 March 2024

97

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Naltrexone and alcohol dependence. Role of subject compliance

24 March 2024

98

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption

24 March 2024

99

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

24 March 2024

100

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A cross-national trial of brief interventions with heavy drinkers. WHO Brief Intervention Study Group

24 March 2024

101

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

The drug treatment of alcohol withdrawal symptoms: a systematic review

24 March 2024

102

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

A comparison of brief advice and conjoint therapy in the treatment of alcohol abuse: the results of the Marital Systems Study

24 March 2024

104

1 reference

https://api.crossref.org/works/10.1097/01.ALC.0000090144.99832.19

24 March 2024

Identifiers

1 reference

4 December 2017

1 reference